|Articles|June 1, 2003
Mycosis Fungoides
San Francisco - When it comes to determining the prognosis of mycosis fungoides, age and disease stage at presentation are particularly important, according to Rosamaria Corona, D.Sc., M.D., a dermatologist and epidemiologist at the Istituto Dermopatico dell'Immacolata (IDI) in Rome.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Lebrikizumab Enters Late-Stage Testing for Nummular Eczema
2
The Weekly Roundup: January 12-16
3
Subgroup Analysis Demonstrates Efficacy of Roflumilast Cream for AD in Pediatric Patients With Diverse Skin Types
4
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
5














